Recent studies demonstrated that Nuclear factor E2-related factor 2 (Nrf2) activation is involved in cancer stem cell-like properties’ exposure to high ALDH1A1 concentrations (9) that result in shorter overall survival (OS) and progression-free survival in ovarian cancer patients (10). This evidence concerns the gene ALDH1A1 and cancer.